Search NLS News

The Board of Directors of Diamyd Medical has appointed Anders Essen-Möller as new Chairman of the Board. Former Chairman Erik Nerpin was appointed Vice Chairman. “Anders Essen-Möller’s importance to Diamyd Medical as founder, former CEO, Board member and not least as an investor, together with his significant experience, can hardly be overestimated,” says Erik Nerpin, […]

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2023 to Moungi G. Bawendi, Louis E. Brus and Alexei I. Ekimo for the discovery and synthesis of quantum dots. The Nobel Prize rewards the discovery and development of quantum dots, nanoparticles so tiny that their size determines their properties. […]

On 1 October, Per Edlund took office as CEO of Bayer AB in Sweden and of Bayer’s pharmaceutical division in the Nordics and Baltics. He comes closest as responsible for Bayer’s pharmaceutical division in Turkey and Iran. He succeeds Tomer Feffer, who has now assumed the role of responsible for Bayer’s operations in one of […]

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Physics 2023 to Pierre Agostini, Ferenc Krausz and Anne L’Huillier for experimental methods that generate attosecond pulses of light for the study of electron dynamics in matter. The three Laureates are being recognised for their experiments, which have given humanity new […]

The newly proposed EU pharmaceutical legislation aims to increase access to medicines for patients in all EU member states, but as the proposed changes in intellectual property rights for new drugs put European innovation at risk it may have the opposite effect. The European Commission put forth its long-awaited proposal for the new European pharmaceutical […]

The Nobel Assembly at Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19. The discoveries were critical for developing effective mRNA vaccines against COVID-19 during […]

Alder Therapeutics is a newly founded preclinical phase stem cell therapy development company with the goal to reshape the cell therapy sector with a novel, reduced-risk approach and two cell therapy candidates for diseases with high unmet need. Alder Therapeutics was formed in 2022 to unlock the benefits of PSCs for patients across the world, […]

Hansa Biopharma has announced that Hitto Kaufmann has been appointed as Hansa’s Chief Scientific Officer (CSO) effective 1 December 2023. As CSO, Kaufmann will be responsible for all research, early development, translational and manufacturing activities. He will report to President & Chief Executive Officer Søren Tulstrup and serve as a member of Hansa’s Executive Committee. […]

NorthX Biologics has announced the official inauguration of its Innovation Hub at the Matfors facility. This milestone marks a major step forward in NorthX’s commitment to the field of advanced therapies in Sweden, states NorthX. The Innovation Hub, co-funded by the Swedish Government, is poised to enhance the country’s infrastructure for cutting-edge therapies and accelerate […]

Abera Bioscience begins cooperation with three strategic investors and in connection with this, the board has decided to carry out a directed new share issue of 1,555,556 shares at a subscription price of SEK 3.60 per share, which adds to the company SEK 5.6 million before issue costs. The three strategic investors are Gunnar Sachs […]